🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Epstein-Barr virus (EBV) infections is known to be a high-risk factor to in...
Status
Completed
Location
Department of Oncology, Xinqiao Hospital
Start Date
2019-03-01
Trial ID
NCT04139057
Treatments Being Tested
TCR-T cell therapy experienced a breakthrough for treating tumors in recent...
Status
Unknown
Location
Fujian Cancer Hospital
Start Date
2018-10-10
Trial ID
NCT03648697
Treatments Being Tested
Epstein-Barr virus (EBV) DNAemia is a common and potentially serious compli...
Status
Recruiting
Location
Chinese PLA General Hospital
Start Date
2025-06-01
Trial ID
NCT07368634
Treatments Being Tested
Patients with medical conditions requiring allogeneic hematopoietic cell tr...
Status
Active Not Recruiting
Location
Houston Methodist Hospital
Start Date
2023-12-06
Trial ID
NCT05236764
Treatments Being Tested
This is a correlative research project aimed at characterizing the T cell m...
Status
Recruiting
Location
Princess Margaret Cancer Centre
Start Date
2020-11-30
Trial ID
NCT04665388
Epstein-Barr virus (EBV) infections is known to be a high-risk factor to in...
Status
Completed
Location
Department of Oncology, Xinqiao Hospital
Start Date
2023-03-01
Trial ID
NCT04509726
Treatments Being Tested
Patients have high-risk neuroblastoma, a form of cancer typically found in ...
Status
Completed
Location
Texas Children's Hospital
Start Date
2003-04
Trial ID
NCT00085930
Treatments Being Tested
In this multi-center open-label, non-randomized phase I/II intervention stu...
Status
Not Yet Recruiting
Location
University Hospital Basel, Klinik für Infektiologie und Spitalhygiene
Start Date
2026-11
Trial ID
NCT05688241
Treatments Being Tested
This is a multi-center, single arm, open-label, phase I study to determine ...
Status
Recruiting
Location
Chinese PLA General Hospital
Start Date
2023-08-01
Trial ID
NCT06119256
Treatments Being Tested
This study was a single-arm, open-label, "3 + 3" dose-escalation Explorator...
Status
Recruiting
Location
Fudan University
Start Date
2022-12-28
Trial ID
NCT05587543
Treatments Being Tested